[1]
|
中国高血压防治指南修订委员会. 中国高血压防治指南(2018) [J]. 中国心血管杂志, 2019, 24(1): 24-56.
|
[2]
|
王聪水, 余振球. 难治性高血压诊断更新与治疗进展[J]. 医学研究杂志, 2017, 46(6): 189-192.
|
[3]
|
Calhoun, D.A., Jones, D., Textor, S., et al. (2008) Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Re-search. Circulation, 117, 510-526. https://doi.org/10.1161/CIRCULATIONAHA.108.189141
|
[4]
|
Siddiqui, M. and Calhoun, D.A. (2016) Refractory versus Resistant Hypertension. Current Opinion in Nephrology and Hypertension, 26, 14-19. https://doi.org/10.1097/MNH.0000000000000286
|
[5]
|
Kumar, N., Calhoun, D.A. and Dudenbostel, T. (2013) Management of Patients with Resistant Hypertension: Current Treatment Options. Integrated Blood Pressure Control, 6, 139-151. https://doi.org/10.2147/IBPC.S33984
|
[6]
|
Carmine, Z. and Francesca, M. (1979) Does a Vitamin D Boost Help in Resistant Hypertension Control? Hypertension, 63, 672-674. https://doi.org/10.1161/HYPERTENSIONAHA.113.02298
|
[7]
|
周岩芬, 杜玉花. 难治性高血压左心室肥厚与交感神经兴奋性关系的临床研究[J]. 国际心血管病杂志, 2017, 44(1): 53-55.
|
[8]
|
Tanaka, S., Ninomiya, T., Hiya-muta, H., et al. (2019) Apparent Treatment Resistant Hypertension and Cardiovascular Risk in Hemodialysis Patients: Ten-Year Outcomes of the Q-Cohort Study. Scientific Reports, 9, Article No. 1043.
https://doi.org/10.1038/s41598-018-37961-1
|
[9]
|
甘林望, 李乾程, 温向琼, 等. 维持性血液透析合并高血压患者难治性高血压的影响因素分析[J]. 中国现代医学杂志, 2016, 26(5): 105-109.
|
[10]
|
Kantauskaite, M., Vonend, O., Yakoub, M., Heilmann, P., Maifeld, A., Minko, P., Schimmöller, L., Antoch, G., Müller, D.N., Schmidt, C., Duvnjak, B., Zierhut, U., Potthoff, S.A., Rump, L.C., Fischer, J.C. and Stegbauer, J. (2023) The Effect of Renal Dener-vation on T Cells in Patients with Resistant Hypertension. International Journal of Molecular Sciences, 24, 2493. https://doi.org/10.3390/ijms24032493
|
[11]
|
庞博, 佟雪, 孙林, 杨波. 维持性血液透析合并难治性高血压的治疗进展[J]. 医学综述, 2021, 27(12): 2371-2376.
|
[12]
|
夏运风, 甘华. 尿毒症难治性高血压的发生机制[J]. 山西医科大学学报, 2002, 33(5): 479-481.
|
[13]
|
Reiss, A.B., Voloshyna, I., De Leon, J., Miyawaki, N. and Mattana, J. (2015) Cholesterol Metabolism in CKD. American Journal of Kidney Diseases, 66, 1071-1082. https://doi.org/10.1053/j.ajkd.2015.06.028
|
[14]
|
Choi, H.Y., Park, H.C. and Ha, S.K. (2014) How Do We Manage Coronary Artery Disease in Patients with CKD and ESRD? Electrolyte Blood Press, 12, 41-54. https://doi.org/10.5049/EBP.2014.12.2.41
|
[15]
|
Stojanovic, V., Doronjski, A., Milak, G. and Barisic, N. (2013) Id-iopathic Arterial Calcification of Infancy—Peritoneal Dialysis for Treatment of Hypertension. Fetal and Pediatric Pa-thology, 32, 443-447.
https://doi.org/10.3109/15513815.2013.802399
|
[16]
|
Masuo, K., Lambert, G.W., Esler, M.D., et al. (2010) The Role of Sympathetic Nervous Activity in Renal Injury and Endstage Renal Disease. Hypertension Research, 33, 521-528. https://doi.org/10.1038/hr.2010.35
|
[17]
|
Koomans, H.A., Blankestijn, P.J. and Joles, J.A. (2004) Sympathetic Hy-peractivity in Chronic Renal Failure: A Wake-Up Call. Journal of the American Society of Nephrology, 15, 524-537.
https://doi.org/10.1097/01.ASN.0000113320.57127.B9
|
[18]
|
Zilch, O., Vos, P.F., Oey, P.L., et al. (2007) Sympa-thetic Hyperactivity in Haemodialysis Patients Is Reduced by Short Daily Haemodialysis. Journal of Hypertension, 25, 1285-1289. https://doi.org/10.1097/HJH.0b013e3280f9df85
|
[19]
|
Agarwal, R., Flynn, J., Pogue, V., et al. (2014) Assessment and Management of Hypertension in Patients on Dialysis. Journal of the American Society of Nephrology, 25, 1630-1646. https://doi.org/10.1681/ASN.2013060601
|
[20]
|
Shafi, T.1., Waheed, S. and Zager, P.G. (2014) Hypertension in Hemodialysis Patients: An Opinion-Based Update. Seminars in Dialysis, 27, 146-153. https://doi.org/10.1111/sdi.12195
|
[21]
|
Kheiri, B., Abdalla, A., Osman, M., et al. (2018) Vitamin D deficiency and Risk of Cardiovascular Diseases: A Narrative Review. Clinical Hypertension, 24, Article No. 9. https://doi.org/10.1186/s40885-018-0094-4
|
[22]
|
Banerjee, S., Basu, S., Akhtar, S., et al. (2019) Free Vitamin D Levels in Steroid-Sensitive Nephrotic Syndrome and Healthy Controls. Pediatric Nephrology, 35, 447-454 https://doi.org/10.1007/s00467-019-04433-1
|
[23]
|
Lavie, C.J., Lee, J.H. and Milani, R.V. (2011) Vitamin D and Cardiovas-Cular Disease Will It Live up to Its Hype? Journal of the American College of Cardiology, 58, 1547-1556. https://doi.org/10.1016/j.jacc.2011.07.008
|
[24]
|
陈秀炎, 张坤英, 赵军, 孔超. 1,25(OH)2D3减轻维持性血液透析患者微炎症状态的作用机制研究进展[J]. 中国血液净化, 2021, 20(9): 617-620.
|
[25]
|
Lee, J.H., O’Keefe, J.H., Bell, D., Hensrud, D.D. and Holick, M.F. (2008) Vitamin D Deficiency an Important, Common, and Easily Treatable Cardiovascular Risk Factor? Journal of the American College of Cardiology, 52, 1949-1956.
https://doi.org/10.1016/j.jacc.2008.08.050
|
[26]
|
陈红艳, 黄柏勇. 120例维持性血液透析患者维生素D水平及相关因素分析[J]. 实用医药杂志, 2015, 32(10): 912-913. https://doi.org/10.14172/j.cnki.issn1671-4008.2015.10.020
|
[27]
|
Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E., Verstuyf, A., Luderer, H.F., Lieben, L., Mathieu, C. and Demay, M. (2008) Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice. Endocrine Reviews, 29, 726-776. https://doi.org/10.1210/er.2008-0004
|
[28]
|
Xiang, W., Kong, J., Chen, S., et al. (2005) Cardiac Hypertrophy in Vitamin D Receptor Knockout Mice: Role of the Systemic and Cardiac Renin-Angiotensin Systems. American Journal of Physiology-Endocrinology and Metabolism, 288, E125-E132. https://doi.org/10.1152/ajpendo.00224.2004
|
[29]
|
Zhang, Z., Chen, F., Li, J., et al. (2018) 1,25(OH)2D3 Suppresses Proinflammatory Responses by Inhibiting Th1 Cell Differentiation and Cytokine Production through the JAK/STAT Pathway. American Journal of Translational Research, 10, 2737-2746.
|
[30]
|
Jiang, S., Huang, L., Zhang, W. and Zhang, H. (2021) Vitamin D/VDR in Acute Kidney Injury: A Potential Therapeutic Target. Current Medicinal Chemistry, 28, 3865-3876. https://doi.org/10.2174/0929867327666201118155625
|
[31]
|
刘宏超, 尹忠诚. 维持性血液透析并发25-羟维生素D缺乏及预后不良的危险因素[J]. 山东医药, 2022, 62(6): 66-68.
|
[32]
|
李小艳, 丁洁, 王学晶, 等. 嘌呤霉素氨基核苷大鼠肾病模型与阿霉素大鼠肾病模型的比较[J]. 中华肾脏病杂志, 2013, 29(2): 137-141.
|